puromycin aminonucleoside has been researched along with Chronic Disease in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (22.73) | 18.7374 |
| 1990's | 12 (54.55) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demirci, S; Kokturk, S; Oztürk, Z; Pekpak, M; Seckin, I; Sonmez, H; Uzunalan, M; Yaprak, E | 1 |
| Dubey, R; Jackson, EK; Salah, EM; Tofovic, SP | 1 |
| Chang, JM; Chen, CA; Chen, HC; Guh, JY; Hwang, JC; Lai, YH | 1 |
| Celik, F; Celik, Y | 1 |
| Gros, F; Gubler, MC; Kleinknecht, C; Laouari, D | 1 |
| Maesaka, J; Schwob, N; Trachtman, H; Valderrama, E | 1 |
| Futterweit, S; Maesaka, J; Schwob, N; Trachtman, H; Valderrama, E | 1 |
| Fan, GM; Kitazawa, K; Sugisaki, T; Wu, JC | 1 |
| Chan, JC; Chan, W; Futterweit, S; Ma, C; Maesaka, J; Trachtman, H; Valderrama, E | 1 |
| Magil, A | 1 |
| Johnson, RJ; Magil, AB; Pichler, RH | 1 |
| Krivoshchapov, LG; Pal'tseva, EM | 1 |
| Heidland, A; Huang, S; Paczek, L; Reisch, S; Schaefer, L; Schaefer, RM; Sebekova, K; Teschner, M | 1 |
| Granados-Silvestre, MA; Hernández-Pando, R; Maldonado, PD; Medina-Campos, ON; Olivares-Corichi, IM; Pedraza-Chaverrí, J | 1 |
| Del Pizzo, R; Futterweit, S; Levine, D; Rao, PS; Sturman, JA; Trachtman, H; Valderrama, E | 1 |
| Chiba, S; Obara, K; Saito, T; Sato, H; Shoji, Y; Soma, J; Yoshinaga, K | 1 |
| Buch, S; Eddy, AA; Jones, CL; Liu, E; McCulloch, L; Post, M | 1 |
| Anderson, S; Diamond, JR | 1 |
| Elema, JD; Grond, J; Muller, EW; van Goor, H; Weening, JJ | 1 |
| Fogo, A; Glick, AD; Homma, T; Ichikawa, I; Yoshida, Y | 1 |
| Fettman, MJ; Radin, MJ; Wilke, WL | 1 |
| Diamond, JR; Karnovsky, MJ | 1 |
22 other study(ies) available for puromycin aminonucleoside and Chronic Disease
| Article | Year |
|---|---|
Experimentally induced puromycine aminonucleoside nephrosis (PAN) in rats: evaluation of angiogenic protein platelet-derived endothelial cell growth factor (PD-ECGF) expression in glomeruli.
Topics: Acute Disease; Albumins; Angiogenic Proteins; Animals; Chronic Disease; Creatinine; Disease Models, Animal; Humans; Hypoxia; Immunohistochemistry; Injections, Subcutaneous; Kidney Glomerulus; Male; Microscopy, Electron, Transmission; Neovascularization, Pathologic; Nephrosis; Platelet-Derived Growth Factor; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar | 2012 |
2-Hydroxyestradiol attenuates renal disease in chronic puromycin aminonucleoside nephropathy.
Topics: Animals; Blood Pressure; Cell Division; Chronic Disease; Collagen Type IV; Cytoprotection; Estradiol; Glomerular Filtration Rate; Immunohistochemistry; Kidney Failure, Chronic; Kidney Tubules; Male; Proliferating Cell Nuclear Antigen; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Reference Values; Transforming Growth Factor beta | 2002 |
Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Topics: Adult; Animals; Antimetabolites, Antineoplastic; Cell Count; Chronic Disease; Female; Glomerulosclerosis, Focal Segmental; Humans; Immunoenzyme Techniques; Integrin alpha3beta1; Male; Microscopy, Immunoelectron; Podocytes; Puromycin Aminonucleoside; Rats; Rats, Wistar | 2006 |
Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Topics: Animals; Chronic Disease; Down-Regulation; Glomerulosclerosis, Focal Segmental; Humans; Integrin alpha3beta1; Kidney; Podocytes; Puromycin Aminonucleoside; Rats | 2006 |
Adverse effect of indomethacin in experimental chronic nephrosis.
Topics: Animals; Chronic Disease; Female; Indomethacin; Kidney; Nephrosis; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Time Factors | 1983 |
Dietary vitamin E supplementation ameliorates renal injury in chronic puromycin aminonucleoside nephropathy.
Topics: Animals; Blood Pressure; Chronic Disease; Diet; Dose-Response Relationship, Drug; Gentamicins; Kidney; Kidney Diseases; Male; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Reference Values; Vitamin E | 1995 |
Recombinant human growth hormone exacerbates chronic puromycin aminonucleoside nephropathy in rats.
Topics: Animals; Chronic Disease; Creatinine; Growth Hormone; Inulin; Kidney; Kidney Diseases; Male; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Recombinant Proteins | 1993 |
The relationship of adhesion molecules and leukocyte infiltration in chronic tubulointerstitial nephritis induced by puromycin aminonucleoside in Wistar rats.
Topics: Animals; Cell Adhesion Molecules; Chronic Disease; Female; Immunoenzyme Techniques; Intercellular Adhesion Molecule-1; Kidney Tubules; Lymphocyte Function-Associated Antigen-1; Nephritis, Interstitial; Nephrotic Syndrome; Puromycin Aminonucleoside; Rats; Rats, Wistar; Time Factors | 1996 |
The effect of recombinant human insulin-like growth factor-I on chronic puromycin aminonucleoside nephropathy in rats.
Topics: Animals; Blood Glucose; Blood Pressure; Chronic Disease; Disease Models, Animal; Humans; Insulin; Insulin-Like Growth Factor I; Kidney Diseases; Kidney Glomerulus; Male; Malondialdehyde; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptor, IGF Type 1; Recombinant Proteins; Weight Gain | 1996 |
Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Chronic Disease; Disease Models, Animal; Disease Progression; Follow-Up Studies; Immunohistochemistry; Infusions, Intravenous; Kidney Glomerulus; Lipid Metabolism; Male; Nephrotic Syndrome; Probucol; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley | 1996 |
Osteopontin in chronic puromycin aminonucleoside nephrosis.
Topics: Animals; Chronic Disease; Immunohistochemistry; In Situ Hybridization; Male; Nephrosis; Osteopontin; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Sialoglycoproteins | 1997 |
[Effects of immunosuppressor and cytostatic agents on the extracellular matrix production during experimental neuropathies].
Topics: Animals; Antineoplastic Agents; Chronic Disease; Cyclophosphamide; Cyclosporine; Extracellular Matrix; Glomerulonephritis; Immunosuppressive Agents; Methylprednisolone; Nephrosis; Puromycin Aminonucleoside; Rats; Rats, Wistar | 1998 |
Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis.
Topics: Animals; Antimetabolites, Antineoplastic; Blood Chemical Analysis; Cathepsins; Chronic Disease; Collagenases; Creatinine; Kidney Glomerulus; Male; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Nephrosis; Puromycin Aminonucleoside; Rats; Rats, Wistar | 1999 |
Garlic ameliorates hyperlipidemia in chronic aminonucleoside nephrosis.
Topics: Animals; Catalase; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chronic Disease; Disease Models, Animal; Garlic; Glutathione Peroxidase; Hydrogen Peroxide; Hyperlipidemias; Hypolipidemic Agents; Kidney; Male; Nephrotic Syndrome; Phytotherapy; Plants, Medicinal; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Superoxide Dismutase; Triglycerides | 2000 |
Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy.
Topics: Animals; Chronic Disease; Creatinine; Kidney; Kidney Diseases; Male; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Taurine | 1992 |
Administration of Triton WR 1339 aggravates chronic aminonucleoside nephrosis.
Topics: Animals; Cholesterol; Chronic Disease; Disease Models, Animal; Drug Synergism; Hyperlipidemias; Injections, Intravenous; Lipid Metabolism; Male; Nephrosis; Polyethylene Glycols; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Triglycerides | 1992 |
Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis.
Topics: Albuminuria; Animals; Chronic Disease; Creatinine; Disease Models, Animal; Extracellular Matrix Proteins; Female; Fibrosis; Gene Expression; Glycoproteins; Macrophages; Metalloendopeptidases; Nephrosis; Puromycin Aminonucleoside; Rats; Rats, Inbred Lew; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta | 1991 |
Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Line; Cell Survival; Chronic Disease; Enalapril; Glomerular Filtration Rate; Kidney; Kidney Tubules; Male; Nephrotic Syndrome; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1990 |
Differences in puromycin aminonucleoside nephrosis in two rat strains.
Topics: Acute Disease; Animals; Chronic Disease; Disease Susceptibility; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Kidney Glomerulus; Male; Nephrosis; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Species Specificity | 1988 |
Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis.
Topics: Animals; Blood Pressure; Blood Urea Nitrogen; Body Weight; Chronic Disease; Disease Models, Animal; Doxorubicin; Glomerular Filtration Rate; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Kidney Glomerulus; Microsurgery; Proteinuria; Punctures; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1988 |
Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats.
Topics: Animals; Captopril; Chronic Disease; Male; Nephrosis; Proteinuria; Puromycin; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1986 |
Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
Topics: Animals; Chronic Disease; Dietary Proteins; Glomerular Filtration Rate; Kidney; Male; Nephrosis; Puromycin; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1987 |